ACOG practice bulletin. Medical management of endometriosis. Number 11, December 1999 (replaces Technical Bulletin Number 184, September 1993). Clinical management guidelines for obstetrician-gynecologists

ACOG Committee on Practice Bulletins--Gynecology, Ben M. Peckham
International Journal of Gynecology & Obstetrics · 2000 · vol. 71(2) , pp. 183–196 · doi:10.1016/s0020-7292(00)80034-x · PMID:11186465 · W2410197530
Guideline OA: closed CC0 ⤵ 53 in-corpus citations
View on OpenAlex View on PubMed View at publisher
⚙ AI-generated summary by gemini-2.5-flash-lite, 2026-07-13 ⓘ

This document presents evidence on the risks and benefits of medical therapy for women experiencing symptoms and problems attributed to endometriosis, a condition affecting women of reproductive age.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

Abstract

Abstract Endometriosis represents a significant health problem for women of reproductive age. Defined as the presence of endometrial‐like glands and stroma in any extrauterine site, endometriosis continues to defy our complete understanding regarding etiology, the relationship between extent of disease and the degree of symptoms, its relationship to fertility, and the most appropriate means of therapy. The purpose of this document is to present the evidence, including risks and benefits, for the effectiveness of medical therapy for women who experience symptoms and problems believed to be secondary to endometriosis.

My notes (saved in your browser only)

Condition tags

endometriosischronic_pelvic_pain

MeSH descriptors

Endometriosis Fertility Agents, Female Gonadotropin-Releasing Hormone Endometriosis Endometriosis Endometriosis Endometriosis Female Female Fertility Agents, Female Fertility Agents, Female Gonadotropin-Releasing Hormone Gonadotropin-Releasing Hormone Humans Humans Pelvic Pain Pelvic Pain Pelvic Pain Pelvic Pain

Citation neighborhood (2-hop)

Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. Outer rings show 2-hop neighbours — papers reached through the immediate citers/citees. [ collapse to 1-hop ]

References (99)

Cited by (50)

Source provenance

europepmc
last seen: 2026-10-16T06:09:50.462052+00:00
openalex
last seen: 2026-06-10T17:14:06.276822+00:00
pubmed
last seen: 2026-10-08T20:59:46.244316+00:00
unpaywall
last seen: 2026-10-16T06:24:35.758740+00:00
License: CC0 · commercial use OK